The economy appears poised to benefit from a COVID-19 vaccine

"Businesses are back to the business of doing business," says RIA Advisors economic strategist Lance Roberts. "What a vaccine does is allow them to expand operation, to attract more business, and take advantage of more things."

AstraZeneca plans to deliver vaccine trial data by year's end

AstraZeneca hopes to show its COVID-19 vaccine is effective by the end of this year and is ramping up manufacturing so it can supply hundreds of millions of doses in January, Chief Executive Pascal Soriot said Thursday.